Literature DB >> 32918748

Regarding "The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors".

Patrick Schöffski1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32918748      PMCID： PMC8186401          DOI： 10.1002/ONCO.13517

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  2 in total

1.  Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.

Authors:  Patrick Schöffski; Jozef Sufliarsky; Hans Gelderblom; Jean-Yves Blay; Sandra J Strauss; Silvia Stacchiotti; Piotr Rutkowski; Lars H Lindner; Michael G Leahy; Antoine Italiano; Nicolas Isambert; Maria Debiec-Rychter; Raf Sciot; Thomas Van Cann; Sandrine Marréaud; Axelle Nzokirantevye; Sandra Collette; Agnieszka Wozniak
Journal:  Lancet Respir Med       Date:  2018-04-15       Impact factor: 30.700

2.  The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis.

Authors:  Giacomo Giulio Baldi; Mehdi Brahmi; Salvatore Lo Vullo; Elena Cojocaru; Olivier Mir; Michela Casanova; Bruno Vincenzi; Tommaso Martino De Pas; Giovanni Grignani; Maria Abbondanza Pantaleo; Jean Yves Blay; Robin Lewis Jones; Axel Le Cesne; Anna Maria Frezza; Alessandro Gronchi; Paola Collini; Angelo Paolo Dei Tos; Carlo Morosi; Luigi Mariani; Paolo Giovanni Casali; Silvia Stacchiotti
Journal:  Oncologist       Date:  2020-07-12
  2 in total
  1 in total

1.  In Reply.

Authors:  Silvia Stacchiotti; Giacomo Giulio Baldi; Paolo Giovanni Casali
Journal:  Oncologist       Date:  2020-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.